From randomized clinical trials to real life data. An Italian clinical experience with ixekizumab and its management.

Damiani, Giovanni; Conic, Rosalynn R Z; Pigatto, Paolo D M; Bragazzi, Nicola L; Pacifico, Alessia; Malagoli, Piergiorgio

Damiani, Giovanni; Conic, Rosalynn R Z; Pigatto, Paolo D M; Bragazzi, Nicola L; Pacifico, Alessia; Malagoli, Piergiorgio.

Affiliation

Damiani G; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Conic RRZ; Clinical Dermatology, IRCCS Istituto Ortopedico Galezzi, Milan, Italy.
Pigatto PDM; Department of Dermatology, Case Western Reserve University, Cleveland, Ohio.
Bragazzi NL; Clinical Dermatology, IRCCS Istituto Ortopedico Galezzi, Milan, Italy.
Pacifico A; School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Malagoli P; San Gallicano Dermatological Institute, IRCCS, Rome, Italy.

Dermatol Ther ; 32(3): e12886, 2019 05.

Article in En | MEDLINE | ID: mdl-30942952

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Interleukin-17/antagonists & inhibitors; Psoriasis/drug therapy; Adult; Female; Humans; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Severity of Illness Index

Key words

DLQI; PASI; UNCOVER-2; UNCOVER-3; injection-site pain; ixekizumab; psoriasis; real-life

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Interleukin-17 / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2019 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google